@article{mbs:/content/journal/jmm/10.1099/jmm.0.000376, author = "Yang, Mina and Huh, Hee Jae and Kwon, Hyeon Jeong and Kim, Ji-Youn and Song, Dong Joon and Koh, Won-Jung and Ki, Chang-Seok and Lee, Nam Yong", title = "Comparative evaluation of the AdvanSure Mycobacteria GenoBlot assay and the GenoType Mycobacterium CM/AS assay for the identification of non-tuberculous mycobacteria", journal= "Journal of Medical Microbiology", year = "2016", volume = "65", number = "12", pages = "1422-1428", doi = "https://doi.org/10.1099/jmm.0.000376", url = "https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.000376", publisher = "Microbiology Society", issn = "1473-5644", type = "Journal Article", keywords = "Mycobacterium avium complex", keywords = "Validation", keywords = "Nontuberculous mycobacteria", keywords = "Line probe assay", keywords = "Identification", abstract = "In this study, to assess the performance of the AdvanSure Mycobacteria GenoBlot assay (AdvanSure assay), we compared its performance with that of the GenoType Mycobacterium CM/AS assay (GenoType assay) for the identification of non-tuberculous mycobacteria (NTM). Twenty-four reference strains and 103 consecutive clinical NTM isolates were analysed. The accuracy rates for the 24 reference strains were 87.5 and 95.8 % for the AdvanSure and GenoType assays, respectively. For the 103 clinical isolates, a 91.3 % (94/103) concordance rate was observed between the two assays. The majority (7/9) of discrepancies were isolates identified as Mycobacterium avium complex (MAC) by only the AdvanSure assay. All of these isolates except one were confirmed as MAC by sequence-based typing. The AdvanSure assay showed comparable performance to the GenoType assay and can be useful as a routine method for NTM identification in the clinical setting, especially where MAC is the main cause of NTM infection.", }